Your Location:
Home >
Browse articles >
Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma:A Multicenter, Randomized Controlled Trial
Original Article | Updated:2023-01-05
    • Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma:A Multicenter, Randomized Controlled Trial

    • Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma:A Multicenter, Randomized Controlled Trial

    • 中国结合医学杂志(英文版)   2023年29卷第1期 页码:3-9
    • DOI:10.1007/s11655-022-3537-4    

      中图分类号:
    • 纸质出版日期:2023-01-01

      网络出版日期:2022-08-01

      录用日期:2022-04-20

    Scan for full text

  • Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma:A Multicenter, Randomized Controlled Trial[J]. 中国结合医学杂志(英文版), 2023,29(1):3-9. DOI: 10.1007/s11655-022-3537-4.

    ZHENG Dong-hai, YANG Jia-mei, WU Jian-xiong, et al. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma:A Multicenter, Randomized Controlled Trial[J]. Chinese Journal of Integrative Medicine, 2023,29(1):3-9. DOI: 10.1007/s11655-022-3537-4.

  •  
  •  
More>

0

浏览量

5

Downloads

0

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway
No Incidence of Liver Cancer Was Observed in A Retrospective Study of Patients with Aristolochic Acid Nephropathy
Pien Tze Huang Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Repressing PDGFRB/YAP/CCN2 Axis Activity
Onset and Recurrence Characteristics of Chinese Patients with Noncardiogenic Ischemic Stroke in Chinese Medicine Hospitals
Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice

相关作者

暂无数据

相关机构

Department of General Surgery, First People's Hospital of Hangzhou Lin'an District
National Key Laboratory of Kidney Diseases
Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Phase Ⅰ Clinical Trials Unit, Department of Medicine for Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital
China Military Institute of Chinese Materia, Fifth Medical Center of Chinese PLA General Hospital
0